East River BioSolutions releases NativeCoat™ ECM substrates

BROOKLYN, New York, Nov. 27, 2018 /PRNewswire/ — East River BioSolutions announced the release of NativeCoat™ ECM – a novel line of 2D in vitro cell culture coatings comprised of native tissue-derived extracellular matrix (ECM) that enables scientists to study cells in their tissue-specific microenvironments, leading to more physiologically relevant testing and thus more accurate and... Read more

Spectro Scientific Acquired by AMETEK, Inc.

November 27, 2018 Spectro Scientific, one of the world’s largest suppliers of fluid analysis instrumentation and software, has been purchased by AMETEK, Inc. Spectro has annual sales of approximately $50 million and was acquired for approximately $190 million. Spectro was a privately held company and is headquartered in Chelmsford, Massachusetts. It joins AMETEK as part... Read more

AddLife acquires Austrian Biomedica – international expansion on 13 new markets

26.11.2018 – 14:00 Life science group AddLife is continuing on its growth journey and is now taking an important step in its expansion and internationalisation strategy by acquiring Austrian Biomedica Medizinprodukte GmbH (“Biomedica”). Biomedica, which is the parent company of a group with sales of about EUR 65 million, engages in operations in 13 countries... Read more

Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies

KEELE, England, PORT WASHINGTON, N.Y. and LONDON, Nov. 26, 2018 /PRNewswire/ — Cobra Biologics, an international contract development and manufacturing organization (CDMO) with a focus on advanced therapy medicinal products (ATMPs) has won a £1.5M shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation, a global leader in filtration, separation and purification, and the Cell and Gene Therapy Catapult, an independent research and technology organization... Read more

Appointment of Non-Executive Chairman

26 November 2018 Oxford Instruments plc, a leading provider of high-technology products, systems and tools for industry and research, today announces the appointment of Neil Carson as Non-Executive Chairman.  He will join the Board with effect from 1st December 2018. Neil Carson is an experienced Chairman and Non-Executive Director.  He is currently Chairman of TT... Read more

LGC acquires Seracare Life Sciences, strengthening its position in clinical quality control tools

26 NOV 2018 Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories. SeraCare provides quality control materials for infectious disease testing through their ACCURUN® reagents as well as in the fast growing clinical next-generation sequencing (NGS) market which it addresses through... Read more

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

November 26, 2018 05:00 AM Pacific Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more... Read more

Fluidic Analytics raises $31m to launch two new products in lab tools pipeline and unlock biology behind major diseases

Cambridge, UK – (26 November 2018) – Fluidic Analytics Ltd has raised $31 million to continue developing its transformational products for characterising proteins and their behaviour. The proceeds of the financing will be used to continue the commercial roll-out of the company’s lab-tools pipeline and to develop further high-value clinical applications of its technology. Proteins and their behaviour... Read more

ATI and Bruker Announce Agreement to Further Advance Niobium-Based Superconductor Technology and Manufacturing Processes

PITTSBURGH, Pennsylvania, November 26, 2018 – Allegheny Technologies Incorporated (NYSE: ATI) and Bruker Energy & Supercon Technologies (BEST), a wholly owned subsidiary of Bruker Corporation, today announced that they have entered into a joint technology development agreement to advance state-of-the-art niobium-based superconductors, including those used in magnetic resonance imaging (MRI) magnets for the medical industry,... Read more

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

November 26, 2018 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more... Read more